260 related articles for article (PubMed ID: 1338980)
1. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
[TBL] [Abstract][Full Text] [Related]
2. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
[TBL] [Abstract][Full Text] [Related]
3. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
[TBL] [Abstract][Full Text] [Related]
4. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
Hewat EA; Blaas D
EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
[TBL] [Abstract][Full Text] [Related]
5. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
6. Structure of human rhinovirus serotype 2 (HRV2).
Verdaguer N; Blaas D; Fita I
J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
[TBL] [Abstract][Full Text] [Related]
7. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
[TBL] [Abstract][Full Text] [Related]
8. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
Tormo J; Blaas D; Parry NR; Rowlands D; Stuart D; Fita I
EMBO J; 1994 May; 13(10):2247-56. PubMed ID: 8194515
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.
Derrick JP; Maiden MC; Feavers IM
J Mol Biol; 1999 Oct; 293(1):81-91. PubMed ID: 10512717
[TBL] [Abstract][Full Text] [Related]
12. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
[TBL] [Abstract][Full Text] [Related]
13. Functional mapping of conserved, surface-exposed charges of antibody variable domains.
Weidenhaupt M; Khalifa MB; Hugo N; Choulier L; Altschuh D; Vernet T
J Mol Recognit; 2002; 15(2):94-103. PubMed ID: 11954054
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
15. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
17. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
[TBL] [Abstract][Full Text] [Related]
18. On the domain pairing in chimeric antibodies.
Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
20. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
Liang M; Chu YK; Schmaljohn C
Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]